Oldridge M, Fortuna A M, Maringa M, Propping P, Mansour S, Pollitt C, DeChiara T M, Kimble R B, Valenzuela D M, Yancopoulos G D, Wilkie A O
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
Nat Genet. 2000 Mar;24(3):275-8. doi: 10.1038/73495.
Inherited limb malformations provide a valuable resource for the identification of genes involved in limb development. Brachydactyly type B (BDB), an autosomal dominant disorder, is the most severe of the brachydactylies and characterized by terminal deficiency of the fingers and toes. In the typical form of BDB, the thumbs and big toes are spared, sometimes with broadening or partial duplication. The BDB1 locus was previously mapped to chromosome 9q22 within an interval of 7.5 cM (refs 9,10). Here we describe mutations in ROR2, which encodes the orphan receptor tyrosine kinase ROR2 (ref. 11), in three unrelated families with BDB1. We identified distinct heterozygous mutations (2 nonsense, 1 frameshift) within a 7-amino-acid segment of the 943-amino-acid protein, all of which predict truncation of the intracellular portion of the protein immediately after the tyrosine kinase domain. The localized nature of these mutations suggests that they confer a specific gain of function. We obtained further evidence for this by demonstrating that two patients heterozygous for 9q22 deletions including ROR2 do not exhibit BDB. Expression of the mouse mouse orthologue, Ror2, early in limb development indicates that BDB arises as a primary defect of skeletal patterning.
遗传性肢体畸形为鉴定参与肢体发育的基因提供了宝贵资源。B型短指症(BDB)是一种常染色体显性疾病,是短指症中最严重的类型,其特征为手指和脚趾末端发育不全。在典型的BDB病例中,拇指和大脚趾不受影响,有时会变宽或出现部分重复。BDB1基因座先前被定位到9号染色体q22区域内一个7.5厘摩的区间(参考文献9、10)。在此,我们描述了三个不相关的BDB1家系中ROR2基因的突变情况,该基因编码孤儿受体酪氨酸激酶ROR2(参考文献11)。我们在这个943个氨基酸的蛋白质的一个7个氨基酸片段内鉴定出了不同的杂合突变(2个无义突变、1个移码突变),所有这些突变都预示着该蛋白质的细胞内部分在酪氨酸激酶结构域之后会立即截短。这些突变的定位性质表明它们赋予了一种特定的功能获得。我们通过证明两名9号染色体q22区域缺失(包括ROR2基因)的杂合患者未表现出BDB,进一步获得了这方面的证据。小鼠同源基因Ror2在肢体发育早期的表达表明,BDB是作为骨骼模式形成的原发性缺陷而出现的。